Abiopharma

🔍 SBLENDORIO GLENN (Executive)

Company: 4D Molecular Therapeutics, Inc. (FDMT)

Report Date: 2026-01-05

Detailed Transactions and Holdings:

• Acquired 45,000 shares of Stock Option (Right to Buy) at $7.3 per share (Derivative)
  Date: 2026-01-05 | Code: A | Expires: 2036-01-04 | equity_swap_involved: false | shares_owned_after: 45,000.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: One-third of the shares subject to the option vest on the first anniversary measured from January 5 2026 (the "Vesting Commencement Date"), and 1/36th of the total number of shares vest in twenty-four (24) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date.